Is a skin biopsy helpful in distinguishing DRESS (Drug Reaction with Eosinophilia and Systemic Symptoms) syndrome from drug-induced lupus?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

A skin biopsy can be helpful in distinguishing DRESS syndrome from drug-induced lupus, though it is not always definitive. When considering the diagnosis of DRESS syndrome versus drug-induced lupus, it's crucial to understand the histopathological features that may aid in differentiation. In DRESS syndrome, skin biopsies typically show interface dermatitis with vacuolar changes, spongiosis, and a dense lymphocytic infiltrate with eosinophils in the dermis, as seen in various studies 1. The presence of significant eosinophilic infiltration is particularly characteristic of DRESS.

Key Histopathological Features

  • Interface dermatitis with vacuolar changes
  • Spongiosis
  • Dense lymphocytic infiltrate with eosinophils in the dermis

In contrast, drug-induced lupus skin biopsies often show interface dermatitis with vacuolar degeneration of the basal layer, but typically lack the prominent eosinophilic component seen in DRESS. Additionally, drug-induced lupus may show immunoglobulin and complement deposition at the dermal-epidermal junction on direct immunofluorescence, which is not typically seen in DRESS, as noted in studies like 1. However, there can be overlap in histological features, so the biopsy should be interpreted alongside clinical presentation, laboratory findings (such as eosinophilia in DRESS and positive ANA in drug-induced lupus), and the specific medication history.

Clinical Considerations

  • Clinical presentation
  • Laboratory findings (eosinophilia, ANA)
  • Medication history (e.g., minocycline, hydralazine, procainamide for drug-induced lupus; aromatic anticonvulsants, allopurinol, sulfonamides for DRESS syndrome)

Given the potential for overlap and the importance of integrating all available information, the decision to perform a skin biopsy should be based on the individual patient's presentation and the need for diagnostic clarity, considering the most recent and highest quality evidence available, such as that from 1.

From the Research

Distinguishing DRESS Syndrome from Drug-Induced Lupus

  • DRESS syndrome and drug-induced lupus are two distinct conditions that can present with similar symptoms, making diagnosis challenging.
  • A skin biopsy may be helpful in distinguishing between the two conditions, as it can provide valuable information about the underlying pathology.

Histopathological Features of DRESS Syndrome

  • Studies have shown that the histopathological features of DRESS syndrome are characterized by interface dermatitis, eczematous patterns, and the presence of eosinophils and neutrophils 2.
  • The association of two or three patterns in a single biopsy is significantly more frequent in cases of DRESS than in nondrug-induced dermatoses.

Role of Skin Biopsy in Diagnosis

  • A skin biopsy can be helpful in the diagnostic process of DRESS syndrome, as it can provide information about the presence of eosinophils, neutrophils, and other inflammatory cells 3.
  • However, the diagnosis of DRESS syndrome is often made based on a combination of clinical and laboratory findings, including the presence of fever, facial edema, lymphadenopathy, and organ involvement.

Comparison with Drug-Induced Lupus

  • Drug-induced lupus is a rare adverse reaction to certain drugs, characterized by symptoms resembling those of idiopathic systemic lupus erythematosus (SLE) 4, 5, 6.
  • The diagnosis of drug-induced lupus is often based on the presence of antinuclear antibodies (ANA) and other autoantibodies, as well as a history of exposure to a specific drug.
  • A skin biopsy may not be as helpful in distinguishing drug-induced lupus from DRESS syndrome, as the histopathological features of drug-induced lupus are not as well characterized.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

DRESS syndrome: A literature review and treatment algorithm.

The World Allergy Organization journal, 2023

Research

Drug-induced lupus erythematosus with emphasis on skin manifestations and the role of anti-TNFα agents.

Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG, 2012

Research

Drug-induced lupus.

Annals of the New York Academy of Sciences, 2007

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.